Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes

被引:33
作者
Yang, Kun [1 ]
Liu, Wenxian [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Cardiac Care Unit,Dept Cardiol, Beijing, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
triglyceride and glucose index (TyG index); major adverse cardiovascular events (MACEs); sex differences; Systolic Blood Pressure Intervention Trial (SPRINT); hypertension; INSULIN-RESISTANCE; BLOOD-PRESSURE; METABOLIC SYNDROME; RISK-FACTOR; 64; COHORTS; DISEASE; METAANALYSIS; INDIVIDUALS; MELLITUS; PRODUCT;
D O I
10.3389/fendo.2021.761397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionStudies from recent decades have suggested that women have a lower risk of cardiovascular disease than men due to their characteristics, but hyperglycemia and hyperinsulinemia caused by IR (insulin resistance) might reverse this gender-protective effect. This study examined whether there were sex differences in the relationship between IR [evaluated by triglyceride and glucose index (TyG index)] and major adverse cardiovascular events (MACEs) in hypertensive patients without diabetes. MethodsThis was a post-hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). We explored the relationship between TyG index and MACEs by multivariate Cox proportional hazard regressions and two-piecewise linear regression models. The primary endpoint was MACEs, same as SPRINT, defined as a composite of myocardial infarction, stroke, heart failure, and/or death from cardiovascular causes. We used multiple adjustment models for all regressions. ResultsA total of 9,323 patients from the SPRINT were included in our analysis. TyG index was significantly related to the risk of MACEs in every adjusted model. Each 1 unit increase in TyG index increased the risk of MACEs in total participants (HR, 1.40; 95% CI, 1.20-1.64; P<0.01) and men (HR, 1.42; 95% CI, 1.18-1.71; P=0.02). However, TyG index was not associated with MACEs among female hypertensive patients (HR, 1.33; 95% CI, 0.97-1.82; P=0.0776). There was no interaction between the sex and TyG index (P for interaction= 0.73). We also used the two-stage linear regression model and did not find any threshold effect. There was no significant interaction in other confounders. ConclusionWe found the TyG index was associated with MACEs in the hypertensive patients, and there was no gender difference between the TyG index and MACEs.
引用
收藏
页数:7
相关论文
共 35 条
  • [1] The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)
    Ambrosius, Walter T.
    Sink, Kaycee M.
    Foy, Capri G.
    Berlowitz, Dan R.
    Cheung, Alfred K.
    Cushman, William C.
    Fine, Lawrence J.
    Goff, David C., Jr.
    Johnson, Karen C.
    Killeen, Anthony A.
    Lewis, Cora E.
    Oparil, Suzanne
    Reboussin, David M.
    Rocco, Michael V.
    Snyder, Joni K.
    Williamson, Jeff D.
    Wright, Jackson T., Jr.
    Whelton, Paul K.
    [J]. CLINICAL TRIALS, 2014, 11 (05) : 532 - 546
  • [2] 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
    Anderson, Todd J.
    Gregoire, Jean
    Pearson, Glen J.
    Barry, Arden R.
    Couture, Patrick
    Dawes, Martin
    Francis, Gordon A.
    Genest, Jacques
    Grover, Steven
    Gupta, Milan
    Hegele, Robert A.
    Lau, David C.
    Leiter, Lawrence A.
    Lonn, Eva
    Mancini, G. B. John
    McPherson, Ruth
    Ngui, Daniel
    Poirier, Paul
    Sievenpiper, John L.
    Stone, James A.
    Thanassoulis, George
    Ward, Richard
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (11) : 1263 - 1282
  • [3] The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
    Barzegar, Niloofar
    Tohidi, Maryam
    Hasheminia, Mitra
    Azizi, Fereidoun
    Hadaegh, Farzad
    [J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [4] Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation
    Beverly, Joshua K.
    Budoff, Matthew J.
    [J]. JOURNAL OF DIABETES, 2020, 12 (02) : 102 - 104
  • [5] Genetics of Insulin Resistance and the Metabolic Syndrome
    Brown, Audrey E.
    Walker, Mark
    [J]. CURRENT CARDIOLOGY REPORTS, 2016, 18 (08)
  • [6] Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
    Cushman, William C.
    Evans, Gregory W.
    Byington, Robert P.
    Goff, David C., Jr.
    Grimm, Richard H., Jr.
    Cutler, Jeffrey A.
    Simons-Morton, Denise G.
    Basile, Jan N.
    Corson, Marshall A.
    Probstfield, Jeffrey L.
    Katz, Lois
    Peterson, Kevin A.
    Friedewald, William T.
    Buse, John B.
    Bigger, J. Thomas
    Gerstein, Hertzel C.
    Ismail-Beigi, Faramarz
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) : 1575 - 1585
  • [7] Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
    Ding, Xiaobo
    Wang, Xiaozhen
    Wu, Jing
    Zhang, Manli
    Cui, Meizi
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [8] Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
    Fiorentino, Teresa Vanessa
    Prioletta, Annamaria
    Zuo, Pengou
    Folli, Franco
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (32) : 5695 - 5703
  • [9] Gambacciani M, 1999, Climacteric, V2, P37
  • [10] Fasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults
    Guerrero-Romero, Fernando
    Villalobos-Molina, Rafael
    Jimenez-Flores, Rafael
    Simental-Mendia, Luis E.
    Mendez-Cruz, Rene
    Murguía-Romero, Miguel
    Rodriguez-Moran, Martha
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2016, 47 (05) : 382 - 387